Pulse Biosciences, Inc. 8-K Filing
Ticker: PLSE · Form: 8-K · Filed: Dec 12, 2025 · CIK: 1625101
| Field | Detail |
|---|---|
| Company | Pulse Biosciences, Inc. (PLSE) |
| Form Type | 8-K |
| Filed Date | Dec 12, 2025 |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by Pulse Biosciences, Inc. (ticker: PLSE) to the SEC on Dec 12, 2025.
What are the key financial figures in this filing?
Key dollar amounts include: $0.001 (nge on Which Registered Common stock , $0.001 par value per share PLSE The Nasdaq).
How long is this filing?
Pulse Biosciences, Inc.'s 8-K filing is 2 pages with approximately 738 words. Estimated reading time is 3 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 738 words · 3 min read · ~2 pages · Grade level 11 · Accepted 2025-12-12 16:04:08
Key Financial Figures
- $0.001 — nge on Which Registered Common stock , $0.001 par value per share PLSE The Nasdaq
Filing Documents
- plse20251208c_8k.htm (8-K) — 56KB
- 0001437749-25-037727.txt ( ) — 185KB
- plse-20251209.xsd (EX-101.SCH) — 3KB
- plse-20251209_def.xml (EX-101.DEF) — 11KB
- plse-20251209_lab.xml (EX-101.LAB) — 15KB
- plse-20251209_pre.xml (EX-101.PRE) — 11KB
- plse20251208c_8k_htm.xml (XML) — 3KB
07
Item 5.07 SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS . On December 9, 2025, Pulse Biosciences, Inc. (the "Company") held its 2025 Annual Meeting of Stockholders (the "Annual Meeting"). The Annual Meeting was a virtual meeting held via live audio webcast. The stockholders of the Company voted on the following items at the Annual Meeting: 1. to elect six directors to hold office until the Company's 2026 annual meeting and until their successors are duly elected and qualified, subject to earlier resignation or removal; 2. to ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025; 3. to approve, by non-binding advisory vote, the compensation of our named executive officers; and 4. to vote on, on an advisory basis, the frequency of future advisory stockholder votes to approve the compensation of our named executive officers. The voting results for each of these proposals are detailed below: 1. Election of Directors Nominee For Against Abstained Broker Non-votes Robert W. Duggan 51,826,494 1,329,627 33,726 9,978,532 Paul A. LaViolette 52,661,322 506,489 22,036 9,978,532 Manmeet S. Soni 52,867,085 275,070 47,692 9,978,532 Darrin R. Uecker 52,633,945 527,159 28,743 9,978,532 Richard A. van den Broek 53,139,403 28,316 22,128 9,978,532 Mahkam Zanganeh, D.D.S. 52,650,407 512,831 26,609 9,978,532 Each director nominee was duly elected to serve until the 2026 Annual Meeting and until his or her successor is duly elected and qualified. 2. Ratification of Appointment of Independent Registered Public Accounting Firm For Against Abstained Broker Non-votes 63,077,669 53,963 36,747 N/A The stockholders ratified the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. 3. Approval of the Compensation of Named E